Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.2379 per EA under NDC 67877045290. Its NADAC has been published 51 times since Jul 9, 2025.
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEStrength
12.5; 40 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877045290
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207037On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has been published 51 times since Jul 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2379 per EA |
|---|---|
| All-time high | $0.2379 (Jun 24, 2026) |
| All-time low | $0.2149 (Feb 18, 2026) |
| 52-week high | $0.2379 |
| 52-week low | $0.2149 |
| Median price | $0.2290 |
| Average price | $0.2281 |
| Largest weekly change | +7.0% (Apr 22, 2026) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.2379 per EA (NDC 67877045290), effective Jun 24, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has held within roughly two percent of its current level. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
Since Jul 9, 2025, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has ranged from a low of $0.2149 (Feb 18, 2026) to a high of $0.2379 (Jun 24, 2026), with a median of $0.2290 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB, is $0.2331 per EA — about 2% below OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB (NDC 67877045290) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification